Current Shareholder Structure (April 12, 2024)
– according to our information –
| Youshi Medical (Suzhou) Co. Ltd., China*¹ | 13.80% |
| Merval AG, Switzerland*² | 9.31% |
| PNO Asset Management GmbH*³ | 9.09% |
| Axxion S.A., Luxemburg | 9.08% |
| ShapeQ GmbH, Germany*⁴ | 9.07% |
| Noes Beheer B.V., Netherlands*⁵ | 8.33% |
| Ratio Capital Management B.V., Netherlands | 7.57% |
| Deepblue Holding AG, Switzerland*⁶ | 4.01% |
| Sum | |
| Free-Float*⁷ | |
| Sum Total | 100% |
| of that Organs (board of directors and supervisory board): | 4.78% |
*1 controlled by Feipeng Huang
*2 controlled by Jürgen W. Krebs
*3 controlled by Dr. G. Haindl
*4 controlled by Simon Haindl
*5 controlled by Jan Albert de Vries
*6 controlled by Rubino di Girolamo
*7 according to Deutsche Börse